Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J05 ANTIVIRALS FOR SYSTEMIC USE
J05A DIRECT ACTING ANTIVIRALS
J05AF Nucleoside and nucleotide reverse transcriptase inhibitors
J05AF08 Adefovir dipivoxil
D01655 Adefovir dipivoxil (USAN) <US>
USP drug classification [BR:br08302]
Antivirals
Anti-hepatitis B (HBV) Agents
Adefovir
D01655 Adefovir dipivoxil (USAN)
Drug groups [BR:br08330]
Antiviral
DG01890 Nucleoside reverse transcriptase inhibitor (NRTI)
DG01224 Adefovir
D01655 Adefovir dipivoxil
Antimicrobials [BR:br08307]
Antivirals
Genome replication inhibitor
HBV reverse transcriptase inhibitor
D01655 Adefovir dipivoxil (USAN) <US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D01655
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D01655
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D01655
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D01655
Prodrugs [br08324.html]
D01655
Drug groups [BR:br08330]
Antiviral
DG01890 Nucleoside reverse transcriptase inhibitor (NRTI)
DG01224 Adefovir
Antimicrobials abbreviations [BR:br08327]
Antivirals
Genome replication inhibitor
HBV reverse transcriptase inhibitor
DG01224 Adefovir